Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer

被引：0
|
作者：
Walter Jentzen
Robert F. Hobbs
Alexander Stahl
Jochen Knust
George Sgouros
Andreas Bockisch
机构：
[1] Universität Duisburg-Essen,Klinik für Nuklearmedizin
[2] Johns Hopkins University,Department of Radiology, School of Medicine
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2010年 / 37卷
关键词：
Radioiodine therapy; Differentiated thyroid cancer; Salivary gland; I; Dosimetry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：884 / 895
页数：11
相关论文
共 50 条
  • [1] Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer
    Jentzen, Walter
    Hobbs, Robert F.
    Stahl, Alexander
    Knust, Jochen
    Sgouros, George
    Bockisch, Andreas
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (05) : 884 - 895
  • [2] Absolute Recovery Coefficients in 124I PET/CT Imaging in 131I Radioiodine Therapy of Thyroid Cancer
    Pigotti, G.
    Martini, D.
    Villano, C.
    De Francesco, V.
    Baldassarrini, E.
    Panichelli, P.
    Valentini, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S253 - S253
  • [3] Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer
    Jentzen, Walter
    Freudenberg, Lutz
    Eising, Emst G.
    Sormenschein, Wilfried
    Knust, Jochen
    Bockisch, Andreas
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (06): : 1017 - 1023
  • [4] Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I
    Pettinato, C.
    Monari, F.
    Nanni, C.
    Allegri, V.
    Marcatili, S.
    Civollani, S.
    Cima, S.
    Spezi, E.
    Mazzarotto, R.
    Fanti, S.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 56 (06): : 509 - 514
  • [5] Comparing pre-therapeutic 124I and 131I uptake tests with intra-therapeutic 131I uptake in benign thyroid disorders
    Guhne, Falk
    Kuhnel, Christian
    Freesmeyer, Martin
    [J]. ENDOCRINE, 2017, 56 (01) : 43 - 53
  • [6] Comparing pre-therapeutic 124I and 131I uptake tests with intra-therapeutic 131I uptake in benign thyroid disorders
    Falk Gühne
    Christian Kühnel
    Martin Freesmeyer
    [J]. Endocrine, 2017, 56 : 43 - 53
  • [7] The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer
    Weber, Manuel
    Binse, Ina
    Nagarajah, James
    Bockisch, Andreas
    Herrmann, Ken
    Jentzen, Walter
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (03): : 235 - 252
  • [8] The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging
    Jentzen, Walter
    Balschuweit, Dorothee
    Schmitz, Jochen
    Freudenberg, Lutz
    Eising, Ernst
    Hilbel, Thomas
    Bockisch, Andreas
    Stahl, Alexander
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (12) : 2298 - 2306
  • [9] The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging
    Walter Jentzen
    Dorothee Balschuweit
    Jochen Schmitz
    Lutz Freudenberg
    Ernst Eising
    Thomas Hilbel
    Andreas Bockisch
    Alexander Stahl
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 2298 - 2306
  • [10] 124I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy 131I SPECT/CT
    Cecile de Pont
    Servais Halders
    Jan Bucerius
    Felix Mottaghy
    Boudewijn Brans
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 693 - 700
12345